Adiponectin receptor 1 expression is associated with carotid plaque stability

Area of Science:

• Cardiovascular Research
• Endocrinology
• Immunology

Background:

• Adiponectin, a hormone from adipose tissue, regulates inflammation and insulin sensitivity.
• Adiponectin acts via Adiponectin receptor 1 (ADR1) and Adiponectin receptor 2 (ADR2).
• The role of ADR1/2 in atherosclerosis progression and plaque vulnerability is not well understood.

Purpose of the Study:

• To examine the association between ADR1/2 expression and carotid artery plaque characteristics.
• To determine if ADR1/2 levels correlate with plaque stability or vulnerability.

Main Methods:

• Carotid plaque specimens from 43 patients undergoing endarterectomy were analyzed.
• Immunohistochemical staining was used to assess ADR1 and ADR2 expression levels.
• Statistical analysis correlated ADR1/2 expression with clinical and plaque characteristics.

Main Results:

• Vulnerable plaques were found in 36 out of 43 patients.
• Weak ADR1 expression significantly correlated with the formation of vulnerable plaques (P < 0.003).
• No significant difference in vulnerable plaque formation was observed based on ADR2 expression levels.

Conclusions:

• ADR1 expression appears crucial for stabilizing atherosclerotic plaques, potentially by inactivating macrophages.
• Increased ADR1 expression may represent a therapeutic strategy to prevent vulnerable plaque development.
• Targeting ADR1 could be a novel approach in managing atherosclerosis.